JIUYUAN GENE(02566.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at CNY 91.27 million, YoY increase of 1.21%

NewTimeSpace News: August 19, 2026, JIUYUAN GENE(02566.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at CNY 630.95 million, decreased by 1.23% YoY; Net Profit stood at CNY 91.27 million, YoY increase of 1.21%; Profit Attributable to Shareholders stood at CNY 91.27 million, YoY increase of 1.21%; Basic Earnings Per Share (EPS) stood at CNY 0.38.

In terms of profitability, JIUYUAN GENE Gross Profit changed from CNY 525.22 million in the same period last year to CNY 511.94 million in the current period, decreased by CNY 13.28 million; gross profit margin changed from 82.22% in the same period last year to 81.14% in the current period, decreased by 1.09 percentage points; net profit changed from CNY 90.17 million in the same period last year to CNY 91.27 million in the current period, increased by CNY 1.1 million; net profit margin changed from 14.12% in the same period last year to 14.47% in the current period, increased by 0.35 percentage points. 

In terms of earnings quality, JIUYUAN GENE Operating Profit changed from CNY 106.95 million in the same period last year to CNY 106.93 million in the current period, decreased by CNY 26 thousand; Operating Profit Margin changed from 16.74% in the same period last year to 16.95% in the current period, increased by 0.2 percentage points. 

In terms of financial soundness, JIUYUAN GENE Debt-to-Asset Ratio changed from 21.73% in the same period last year to 21.7% in the current period, decreased by 0.03 percentage points; Total Equity changed from CNY 1.597 billion in the same period last year to CNY 1.687 billion in the current period, increased by CNY 89.75 million; Current Liabilities changed from CNY 322.76 million in the same period last year to CNY 335.7 million in the current period, increased by CNY 12.94 million; Quick Ratio changed from 4.03 in the same period last year to 3.82 in the current period, decreased by 0.21 percentage points. 

In terms of R&D investment focus, JIUYUAN GENE R&D Expenses changed from CNY 49.63 million in the same period last year to CNY 69.3 million in the current period, increased by CNY 19.67 million; R&D to Total Revenue Ratio changed from 7.77% in the same period last year to 10.98% in the current period, increased by 3.21 percentage points. 

NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.